ArticleCancers2022

Syntaxin-6, a Reliable Biomarker for Predicting the Prognosis of Patients with Cancer and the Effectiveness of Immunotherapy.

Wenchao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.